EU regulator backs J&J vaccine, despite risk

Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. Olivia Chan reports.